Bronchiectasis

Edited by James D. Chalmers, Amelia Shoemark and Stefano Aliberti
Once considered an orphan condition, bronchiectasis is now recognised as a common and actionable chronic respiratory disease with an expanding clinical and research community. The European Respiratory Society (ERS) has taken the lead in this area by supporting the European Multicentre Audit and Research Collaboration (EMBARC), a project that has done much to help understanding of bronchiectasis. In this Monograph, key leaders of EMBARC, James D. Chalmers, Amelia Shoemark and Stefano Aliberti, have brought together comprehensive and authoritative chapters covering epidemiology, imaging, current management advice, future therapeutic options and the challenges to come. This Monograph will provide clinicians, researchers and allied health professionals with the knowledge and tools required to improve the qualtity of life of people living with bronchiectasis.

Contents list 
1. Understanding bronchiectasis through patient voices
2. Epidemiology of bronchiectasis
3. The basics of bronchiectasis
4. Radiology in bronchiectasis: from radiological signs to quantifiable disease
5. The immunology of bronchiectasis
6. Mucociliary clearance in bronchiectasis
7. Chronic airway infection and the microbiome in bronchiectasis
8. Primary ciliary dyskinesia
9. Allergic bronchopulmonary aspergillosis
10. Autoimmune conditions and bronchiectasis
11. COPD, asthma and bronchiectasis overlap
12. Nontuberculous mycobacterial infections and bronchiectasis
13. Investigation and management of immunodeficiency disorders in bronchiectasis
14. Protracted bacterial bronchitis and "pre-bronchiectasis"
15. Principles of management: an overview of the 2025 European Respiratory Society bronchiectasis guidelines
16. Airway clearance management in bronchiectasis: techniques, devices and mucoactive agents
17. Antibiotic management: macrolides and inhaled antibiotics
18. Dipeptidyl peptidase-1 inhibitors in bronchiectasis
19. Investigation and management of the deteriorating patient
20. Acute exacerbations of bronchiectasis
21. Bronchiectasis in children
22. Bronchiectasis clinical trial design considerations
23. The bronchiectasis treatment pipeline
24. What have we learned from the EMBARC project?
25. Research priorities and progress for bronchiectasis

Print ISBN: 978-1-84984-199-3
eISBN: 978-1-84984-200-6
EPUB ISBN: 978-1-84984-201-3